missing translation for 'onlineSavingsMsg'
Learn More

myogenic differentiation 1, Mouse, Polyclonal Antibody, Abnova™

Mouse polyclonal antibody raised against a partial recombinant MYOD1.

Brand:  Abnova H00004654-A01.50uL

Product Code. 16131625

  • £209.00 / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

This gene encodes a nuclear protein that belongs to the basic helix-loop-helix family of transcription factors and the myogenic factors subfamily. It regulates muscle cell differentiation by inducing cell cycle arrest, a prerequisite for myogenic initiation. The protein is also involved in muscle regeneration. It activates its own transcription which may stabilize commitment to myogenesis. [provided by RefSeq

Sequence: MDYSGPPSGARRRNCYEGAYYNEAPSEPRPGKSAAVSSLDCLSSIVERISTESPAAPALLLADVPSESPPRRQEAAAPSEGESSGDPTQSPDAAPQCPAGANPNPIYQVL
Specifications

Specifications

myogenic differentiation 1
Polyclonal
Mouse polyclonal antibody raised against a partial recombinant MYOD1.
MYOD1
MYF3/MYOD/PUM/bHLHc1
Mouse
50 μL
Transcription Regulation
Primary
Human
Serum
ELISA, Western Blot
Unconjugated
50% glycerol
NM_002478
MYOD1
MYOD1 (NP_002469, 211 a.a. ∼ 320 a.a) partial recombinant protein with GST tag.
RUO
Yes
4654
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.